CompletedNCT01266174
What is this study about?Researchers compared Eltoprazine and placebo to find out how the approaches affected memory, attention and other thinking skills in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Amarantus BioScience Holdings, Inc.
CompletedNCT01641900
Official study titleSleep-dependent Memory Processing in Schizophrenia
This study has finished and is no longer accepting participants.
In BostonSchizophreniaMedication studyAges 18–45
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT00833547
This study has finished and is no longer accepting participants.
In BostonSchizophreniaMedication studyAges 18–45
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT01614093
This study has finished and is no longer accepting participants.
In CatonsvilleSchizophreniaMedication studyAges 18–54
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
CompletedNCT01140620
Official study titleEffects of NMDA Receptor Antagonism on Cognitive Processes in Healthy Volunteers and Its Reversal by a Dopamine Antagonist: Comparison to Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including LondonSchizophreniaMedication studyAges 18–45
- Countries
- United Kingdom
- Sponsor
- University of Manchester
CompletedNCT00559572
Official study titleMotivating Persons With Schizophrenia to Exercise
This study has finished and is no longer accepting participants.
In KnoxvilleSchizophreniaBehavioural studyAges 22+
- Countries
- United States
- Sponsor
- The University of Tennessee, Knoxville
CompletedNCT03967431
Official study titleEffects of Narrative Enhancement and Cognitive Therapy (NECT) on Self-stigma in Patients With Schizophrenia: A Randomized Controlled Study
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaInterventional studyAges 20–64
- Countries
- Taiwan
- Sponsor
- National Yang Ming Chiao Tung University
CompletedNCT01034085
This study has finished and is no longer accepting participants.
In CatonsvilleSchizophrenia, AddictionObservational studyAges 18–55
- Countries
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
CompletedNCT03662425
Official study titleEffects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Behavioral Mechanisms
This study has finished and is no longer accepting participants.
In ShanghaiSchizophreniaMedication studyAges 18–55
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
CompletedNCT03714698
Official study titleEffects of Pilates-based Exercises on Functional Capacity and Mental Health in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In ZonguldakSchizophreniaPlacebo comparisonAges 35–40
- Countries
- Türkiye
- Sponsor
- Hacettepe University
CompletedNCT00235274
This study has finished and is no longer accepting participants.
In IndianapolisSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Indiana University
CompletedNCT01523730
Official study titleEffects of Repetitive Transcranial Magnetic Stimulation on Cigarette Smoking and Cognitive Function in Smokers With and Without Schizophrenia
This study has finished and is no longer accepting participants.
In TorontoSchizophrenia, AddictionDevice studyAges 18–55
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)